Amundi Bio N Tech Se Transaction History

Amundi

$264 Billion
Q3 2024

A detailed history of Amundi transactions in Bio N Tech Se stock. As of the latest transaction made, Amundi holds 366,671 shares of BNTX stock, worth $43 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

366,671

Previous 273,846 33.9%

Holding current value

$43 Million

Previous $22 Million 97.9%

% of portfolio

0.02%

Previous 0.01%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$78.36 - $124.66 $7.27 Million - $11.6 Million	92,825 Added 33.9%	366,671 $43.5 Million
Q2 2024 Aug 14, 2024	BUY	$80.36 - $102.87 $645,612 - $826,457	8,034 Added 3.02%	273,846 $22 Million
Q1 2024 May 15, 2024	BUY	$88.96 - $112.35 $1.67 Million - $2.11 Million	18,796 Added 7.61%	265,812 $24.5 Million
Q4 2023 Feb 14, 2024	BUY	$90.91 - $112.75 $20.2 Million - $25.1 Million	222,724 Added 916.86%	247,016 $26.1 Million
Q3 2023 Nov 14, 2023	BUY	$98.5 - $125.08 $662,314 - $841,037	6,724 Added 38.27%	24,292 $2.64 Million
Q2 2023 Aug 14, 2023	BUY	$102.58 - $129.66 $49,853 - $63,014	486 Added 2.85%	17,568 $1.9 Million
Q1 2023 May 15, 2023	BUY	$122.57 - $153.67 $18,508 - $23,204	151 Added 0.89%	17,082 $2.13 Million
Q4 2022 Feb 14, 2023	BUY	$118.43 - $186.05 $97,231 - $152,747	821 Added 5.1%	16,931 $2.54 Million
Q3 2022 Nov 14, 2022	BUY	$127.65 - $183.11 $1.59 Million - $2.29 Million	12,479 Added 343.68%	16,110 $2.21 Million
Q2 2022 Aug 15, 2022	BUY	$123.25 - $186.24 $116,841 - $176,555	948 Added 35.33%	3,631 $561,000
Q1 2022 May 16, 2022	SELL	$126.25 - $231.85 $19,442 - $35,704	-154 Reduced 5.43%	2,683 $454,000
Q4 2021 Feb 14, 2022	SELL	$216.64 - $362.52 $342,074 - $572,419	-1,579 Reduced 35.76%	2,837 $576,000
Q3 2021 Nov 15, 2021	BUY	$205.93 - $447.23 $497,115 - $1.08 Million	2,414 Added 120.58%	4,416 $1.21 Million
Q2 2021 Aug 16, 2021	BUY	$113.32 - $241.49 $226,866 - $483,462	2,002 New	2,002 $448,000

Others Institutions Holding BNTX

# of Institutions

358

Shares Held

38.4M

Call Options Held

2.45M

Put Options Held

2.29M

View Full List

About BioNTech SE

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $28.5B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

More about BNTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Amundi, based on Form 13F filings with the SEC.

News

Stay updated on Amundi with notifications on news.

Account